Combining AOD-9604 and 5-Amino-1MQ creates synergy through complementary metabolic pathways: AOD-9604 stimulates lipolysis via beta-3 adrenergic receptors to mobilise stored triglycerides, while 5-Amino-1MQ inhibits NNMT enzyme activity to restore NAD+ availability and mitochondrial oxidative capacity
Evidence and Procedure Any classification change request must be supported by strong evidence that demonstrates the risk to the public will be adequately managed
1 2 3 "Contributions of microbes in vertebrate gastrointestinal tract to production and conservation of nutrients"
Human mutation, 13(5), 362375.[PubMed] [Wiley] Lalouschek, W., Aull, S., Serles, W., Schnider, P., Mannhalter, C., Lang, T., Deecke, L., & Zeiler, K
Oral administration allows for easy daily use without the discomfort, complexity or potential side effects associated with injections